SS&C Intralinks Success Stories

We’ve helped clients in nearly every country and industry throughout the world with secure innovative, productivity-driving solutions for high-value M&A, debt capital markets and banking transactions.

Here are just a few of our recent success stories. We’d love to add your brand to our hall of fame.

USD 200 million

Eureka IV
Eureka IV targets investments in profitable businesses with up to USD 100 million in revenue. The fund focuses on companies located in the Mid-Atlantic and Eastern US.

USD 17.77 billion

Thoma Bravo Fund XIV
Thoma Bravo Fund XIV is the 14th fund in the series. The fund will continue to invest in the software and technology sectors.
true-ventures.png

USD 465 million

True Ventures
True Ventures VII is an early stage venture capital fund which invests in technology startups, including ecommerce, consumer devices, media, mobile, software and services.
carousellogo.jpg

USD 700 million

Carousel Capital Partners VI
Carousel Capital Partners VI focuses on acquiring non-cyclical, growth-oriented companies headquartered in Southeastern U.S.
One Rock Capital Partners III

USD 2.01 billion

One Rock Capital Partners III
One Rock Capital Partners III seeks to invest in North America-based mid-market companies across a diverse range of industries.
Development Partners International

USD 900 million​

African Development Partners III
African Development Partners III is the firm's third growth fund dedicated to investments in companies serving Africa's middle class. ​
Aisling Capital

USD 209.1 million​

Aisling Capital V​
Aisling Capital V invests in life science companies. With Aisling Capital V, the team will seek to capture promising returns for their partners by investing in innovative therapeutics, with the intention of elevating the standard of care for millions of patients.​
Aldrich Capital Partners

USD 450 million​

Aldrich Capital Partners
Aldrich Capital Partners II will invest in U.S. companies in sectors such as business services, software & cloud-services, Fin-Tech, healthcare IT, and the internet.​
Antler Global Fund​

USD 300 million​

Antler Global Fund​
Antler Global Fund is a venture capital fund that invests in the pre-seed stage in technology companies globally.​
Antler Global Fund​

USD 30 million​

Antler Southeast Asia Fund​
Antler Southeast Asia Fund is an early stage fund that focuses on technology investments in the Southeast Asia region. ​
Avance Univista Co-Investors​

USD 74.5 million​

Avance Univista Co-Investors​
Avance Univista Co-Investors is a private fund managed by Avance Investment Management that targets a range of industries.​
Breakthrough Energy

USD 1 billion​

Breakthrough Energy Ventures II​
The Breakthrough Energy Ventures II follows its predecessor and focuses on innovations in the cleantech sector specifically to reduce greenhouse-gas emissions.​
Charlesbank Equity Fund X​

USD 3.75 billion​

Charlesbank Equity Fund X​
Charlesbank Equity Partners X executes control buyouts and occasional minority equity investments in middle market companies across North America.​
CLP WIS Co-Invest​

USD 207.6 million​

CLP WIS Co-Invest​
CLP WIS Co-Invest is a fund managed by Centre Lane Partners that invests in a diversified range of industries.​
Coller International Partners VIII​

USD 9 billion​

Coller International Partners VIII​
Coller International Partners VIII will continue the strategy of its predecessors, purchasing portfolios of private equity assets including interests in established private equity funds and privately held companies.​
CoinFund VC Fund III​

USD 83 million​

CoinFund VC Fund III​
CoinFund Venture Capital III invests in blockchain and crypto opportunities across the United States.​
Cordillera Investment Fund II

USD 362 million

Cordillera Investment Fund II
Cordillera Investment Fund II is the firm’s 2nd growth equity fund. The fund focuses on assets and companies that are undercapitalized and don't fit neatly into traditional asset classes.
Co-win Healthcare Fund III

USD 150 million​

Co-win Healthcare Fund III
Co-win Healthcare Fund III is a growth fund managed by Co-win Ventures. The fund is a biotechnology-focused fund that invests in biotechnology, medical equipment, healthcare IT, and pharmaceuticals industries globally.​